Morning Edition picked up the theme of patent protection for prescription drugs providing a trade-off between affordability and innovation seen in the NYT today. This is an inaccurate description of the issues, since there are other more efficient mechanisms for financing research. The patent system for financing drug research both leads to bad health outcomes and is a substantial drag on growth and job creation since it pulls hundreds of billions of dollars out of consumers' pockets every year. It would be good if NPR would stop getting the framing for such pieces from the drug industry.

Leave your comments

Post comment as a guest

0
  • No comments found

GuideStar Exchange Gold charity navigator LERA cfc IFPTE

contact us

1611 Connecticut Ave., NW
Suite 400
Washington, DC 20009
(202) 293-5380
info@cepr.net

let's talk about it

Follow us on Twitter Like us on Facebook Follow us on Tumbler Connect with us on Linkedin Watch us on YouTube Google+ feed cepr.net rss feed